VOL. XCIV, NO. 247

* MOAT STOCKS COMPARISON *

NO ADVICE

Friday, December 26, 2025

Stock Comparison

PepsiCo, Inc. vs West Pharmaceutical Services, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

PepsiCo, Inc.

PEP · Nasdaq Global Select Market

Market cap (USD)$199.4B
SectorConsumer
CountryUS
Data as of2025-12-23
Moat score
72/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

View full moat analysis >

West Pharmaceutical Services, Inc.

WST · New York Stock Exchange

Market cap (USD)
SectorHealthcare
CountryUS
Data as of2025-12-22
Moat score
85/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

View full moat analysis >

Side-by-side metrics

PepsiCo, Inc.
West Pharmaceutical Services, Inc.
Ticker / Exchange
PEP - Nasdaq Global Select Market
WST - New York Stock Exchange
Market cap (USD)
$199.4B
n/a
Sector
Consumer
Healthcare
HQ country
US
US
Primary segment
Frito-Lay North America (FLNA)
Proprietary Products
Market structure
Oligopoly
Quasi-Monopoly
Market share
54%-58% (implied)
70%-75% (reported)
HHI estimate
3,530
n/a
Pricing power
Moderate
Moderate
Moat score
72 / 100
85 / 100
Moat domains
Supply, Demand
Demand, Legal, Supply
Last update
2025-12-23
2025-12-22

Moat coverage

Shared moat types

Brand Trust

PepsiCo, Inc. strengths

Distribution ControlScale Economies Unit CostScope Economies

West Pharmaceutical Services, Inc. strengths

Design In QualificationCompliance AdvantageCapex Knowhow ScaleOperational Excellence

Segment mix

PepsiCo, Inc. segments

Full profile >

Frito-Lay North America (FLNA)

Oligopoly

27%

Quaker Foods North America (QFNA)

Competitive

4.2%

PepsiCo Beverages North America (PBNA)

Oligopoly

19.9%

Latin America (LatAm)

Oligopoly

12.3%

Europe

Oligopoly

22.4%

Africa, Middle East and South Asia (AMESA)

Competitive

8.8%

Asia Pacific, Australia & New Zealand and China Region (APAC)

Competitive

5.5%

West Pharmaceutical Services, Inc. segments

Full profile >

Proprietary Products

Quasi-Monopoly

80.7%

Contract-Manufactured Products

Competitive

19.3%

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.